IPP Bureau
Granules India update on USFDA inspection at Gagillapur facility
By IPP Bureau - December 05, 2024
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
Alembic Pharmaceuticals gets USFDA tentative approval for OTC
By IPP Bureau - December 05, 2024
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
Lupin gets tentative approval from USFDA for Sitagliptin and Metformin Hydrochloride Tablets
By IPP Bureau - December 05, 2024
Sitagliptin and Metformin Hydrochloride Tablets, 50 mg/500 mg and 50 mg/1000 mg are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Aster and Blackstone-backed Quality Care to merge and create hospital chains in India
By IPP Bureau - December 04, 2024
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
Biocon celebrates 46th Founder’s Day
By IPP Bureau - December 04, 2024
The celebrations began with the unveiling of the Biocon Anthem
Ann-Xiaoyan Li appointed Group CFO and MD of Romaco Group
By IPP Bureau - December 04, 2024
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
Gland Pharma receives approval for Latanoprost Opthalmic Solution, 0.005%
By IPP Bureau - December 04, 2024
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
Dr. Reddy's launches Toripalimab in India
By IPP Bureau - December 01, 2024
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Aster DM Healthcare to acquire the balance stake in Aster Aadhar Hospital
By IPP Bureau - November 28, 2024
The 254-bedded Aster Aadhar Hospital, Kolhapur is the city's most comprehensive multi-speciality hospital
Glenmark Pharmaceuticals USA launches Travoprost Ophthalmic Solution USP, 0.004%
By IPP Bureau - November 28, 2024
Glenmark's Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004% of Sandoz
Granules' net zero commitment approved by SBTi
By IPP Bureau - November 28, 2024
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
Fredun Pharmaceuticals to launch advanced functional foods plant
By IPP Bureau - November 28, 2024
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
By IPP Bureau - November 28, 2024
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
Senores Pharmaceuticals launches Ivermectin Tablets in US with Dr. Reddy's Laboratories
By IPP Bureau - November 28, 2024
The product will be marketed by Dr. Reddy's
